GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 6 filers reported holding GLAXOSMITHKLINE PLC in Q4 2011. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q3 2014 | $1,545,000 | -14.0% | 33,600 | 0.0% | 0.02% | -15.0% |
Q2 2014 | $1,797,000 | +1098.0% | 33,600 | +1100.0% | 0.02% | +900.0% |
Q1 2014 | $150,000 | +0.7% | 2,800 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $149,000 | +6.4% | 2,800 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $140,000 | 0.0% | 2,800 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $140,000 | +6.9% | 2,800 | 0.0% | 0.00% | 0.0% |
Q1 2013 | $131,000 | +7.4% | 2,800 | 0.0% | 0.00% | 0.0% |
Q4 2012 | $122,000 | -5.4% | 2,800 | 0.0% | 0.00% | 0.0% |
Q3 2012 | $129,000 | +0.8% | 2,800 | 0.0% | 0.00% | -33.3% |
Q2 2012 | $128,000 | +1.6% | 2,800 | 0.0% | 0.00% | +50.0% |
Q1 2012 | $126,000 | -1.6% | 2,800 | 0.0% | 0.00% | -33.3% |
Q4 2011 | $128,000 | +10.3% | 2,800 | 0.0% | 0.00% | 0.0% |
Q3 2011 | $116,000 | -3.3% | 2,800 | 0.0% | 0.00% | 0.0% |
Q2 2011 | $120,000 | +0.8% | 2,800 | -9.7% | 0.00% | 0.0% |
Q1 2011 | $119,000 | -2.5% | 3,100 | 0.0% | 0.00% | 0.0% |
Q4 2010 | $122,000 | – | 3,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |